Literature DB >> 17131142

Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.

A Fodor1, C Harel, L Fodor, M Armoni, P Salmon, D Trono, E Karnieli.   

Abstract

AIMS/HYPOTHESIS: We examined a clinical model of ex vivo transdifferentiation of primary adult hepatocytes to insulin-secreting cells for the treatment of type 1 diabetes.
MATERIALS AND METHODS: Isolated rat hepatocytes were transduced in primary culture with a human lentivirus containing pancreatic duodenal homeobox 1 (PDX1, now known as insulin promoter factor 1, homeodomain transcription factor [IPF1]). Insulin expression and secretion of the newly engineered cells were assessed in vitro by RT-PCR, in situ hybridisation, immunostaining and radioimmunoassay. PDX1-transduced hepatocytes were further studied in vivo by injecting them under the renal capsule of diabetic SCID mice.
RESULTS: Isolated rat hepatocytes were efficiently transduced with the lentiviral vector, as assessed by green fluorescent reporter gene expression. The transduced cells exhibited insulin at both mRNA (RT-PCR, in situ hybridisation) and protein levels (immunostaining and radioimmunoassay). Moreover, insulin secretion by the engineered cells was dependent on glucose and sulfonylurea. Other beta cell genes, including those encoding solute carrier family 2 (facilitated glucose transporter), member 2 (Slc2a2), glucokinase (Gck), ATP-binding cassette, sub-family C (CFTR/MRP), member 8 (Abcc8), the potassium inwardly-rectifying channel, subfamily J, member 11 (Kcnj11) and proprotein convertase subtilisin/kexin type 1 (Pcsk1) were also expressed. The PDX1-transduced hepatocytes expressed several pancreatic transcription factors related to early pancreatic endocrine development (endogenous Pdx1, neurogenic differentiation factor 1 [Neurod1], and NK6 transcription factor related, locus 1 [Nkx6-1]) as well as the late-stage pancreatic transcription factors (paired box gene 4 [Pax4], paired box gene 6 [Pax6], and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A [Mafa]). Transplantation of 3 x 10(6) transdifferentiated liver cells under the renal capsule of seven streptozotocin-induced diabetic SCID mice resulted in significant reduction of non-fasting blood glucose levels from 30.7 +/- 1.3 to 8.7 +/- 3.7 mmol/l (mean +/- SEM, p = 0.01), in 6 to 8 weeks. Removal of the graft resulted in severe hyperglycaemia. CONCLUSIONS/
INTERPRETATION: Ex vivo lentiviral-mediated PDX1 expression in isolated adult liver cells represents a potential model for type 1 diabetes mellitus therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131142     DOI: 10.1007/s00125-006-0509-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

1.  Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo.

Authors:  D de la Tour; T Halvorsen; C Demeterco; B Tyrberg; P Itkin-Ansari; M Loy; S J Yoo; E Hao; S Bossie; F Levine
Journal:  Mol Endocrinol       Date:  2001-03

2.  Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

Authors:  N Lumelsky; O Blondel; P Laeng; I Velasco; R Ravin; R McKay
Journal:  Science       Date:  2001-04-26       Impact factor: 47.728

3.  Auto-regulated hepatic insulin gene expression in type 1 diabetic rats.

Authors:  R Chen; M L Meseck; S L Woo
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

4.  In vitro cultivation of human islets from expanded ductal tissue.

Authors:  S Bonner-Weir; M Taneja; G C Weir; K Tatarkiewicz; K H Song; A Sharma; J J O'Neil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells.

Authors:  Li-Zhen Cao; Dong-Qi Tang; Marko E Horb; Shi-Wu Li; Li-Jun Yang
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

6.  KATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting.

Authors:  H Malhi; A N Irani; P Rajvanshi; S O Suadicani; D C Spray; T V McDonald; S Gupta
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

7.  Insulin staining of ES cell progeny from insulin uptake.

Authors:  Jayaraj Rajagopal; William J Anderson; Shoen Kume; Olga I Martinez; Douglas A Melton
Journal:  Science       Date:  2003-01-17       Impact factor: 47.728

8.  The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site.

Authors:  P Serup; H V Petersen; E E Pedersen; H Edlund; J Leonard; J S Petersen; L I Larsson; O D Madsen
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

9.  beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes.

Authors:  U Ahlgren; J Jonsson; L Jonsson; K Simu; H Edlund
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

10.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

Authors:  M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  13 in total

1.  Pancreatic and duodenal homeobox gene 1 (Pdx1) down-regulates hepatic transcription factor 1 alpha (HNF1α) expression during reprogramming of human hepatic cells into insulin-producing cells.

Authors:  William Donelan; Shiwu Li; Hai Wang; Shun Lu; Chao Xie; Dongqi Tang; Lung-Ji Chang; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  Gene therapy in diabetes.

Authors:  Mary S Wong; Wayne J Hawthorne; Nicholas Manolios
Journal:  Self Nonself       Date:  2010-06-09

Review 3.  The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue.

Authors:  D Gerace; R Martiniello-Wilks; B A O'Brien; A M Simpson
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

4.  Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.

Authors:  Fabrizio Thorel; Virginie Népote; Isabelle Avril; Kenji Kohno; Renaud Desgraz; Simona Chera; Pedro L Herrera
Journal:  Nature       Date:  2010-04-04       Impact factor: 49.962

Review 5.  Promoting ectopic pancreatic fates: pancreas development and future diabetes therapies.

Authors:  E J Pearl; M E Horb
Journal:  Clin Genet       Date:  2008-09-09       Impact factor: 4.438

6.  Distinct regulation of hepatic nuclear factor 1alpha by NKX6.1 in pancreatic beta cells.

Authors:  William Donelan; Vijay Koya; Shi-Wu Li; Li-Jun Yang
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

7.  Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.

Authors:  B Ren; B A O'Brien; M A Swan; M E Koina; N Nassif; M Q Wei; A M Simpson
Journal:  Diabetologia       Date:  2007-06-28       Impact factor: 10.122

8.  Pdx-1 or Pdx-1-VP16 protein transduction induces beta-cell gene expression in liver-stem WB cells.

Authors:  Juliette Cuvelier Delisle; Lionel Martignat; Laurence Dubreil; Pierre Saï; Jean-Marie Bach; Vanessa Louzier; Steffi Bösch
Journal:  BMC Res Notes       Date:  2009-01-09

9.  Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model.

Authors:  Nelson K F Chen; Jen San Wong; Irene H C Kee; Siang Hui Lai; Choon Hua Thng; Wai Har Ng; Robert T H Ng; Soo Yong Tan; Shu Yen Lee; Mark E H Tan; Jaichandran Sivalingam; Pierce K H Chow; Oi Lian Kon
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

Review 10.  Stem cells in the adult pancreas and liver.

Authors:  Zoë D Burke; Shifaan Thowfeequ; Macarena Peran; David Tosh
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.